Drug Information

Drug General Information
Drug ID
D06QGJ
Former ID
DNC011214
Drug Name
3-(1-benzylpiperidin-4-yloxy)benzamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [531117]
Structure
Download
2D MOL

3D MOL
Formula
C19H22N2O2
Canonical SMILES
C1CN(CCC1OC2=CC=CC(=C2)C(=O)N)CC3=CC=CC=C3
InChI
1S/C19H22N2O2/c20-19(22)16-7-4-8-18(13-16)23-17-9-11-21(12-10-17)14-15-5-2-1-3-6-15/h1-8,13,17H,9-12,14H2,(H2,20,22)
InChIKey
IDSIUINGWBNUFD-UHFFFAOYSA-N
PubChem Compound ID
52946209
Target and Pathway
Target(s) Kappa-type opioid receptor Target Info Inhibitor [531117]
KEGG Pathway Neuroactive ligand-receptor interaction
PANTHER Pathway Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
Opioid prodynorphin pathway
Reactome Peptide ligand-binding receptors
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Peptide GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 531117Bioorg Med Chem Lett. 2010 Oct 1;20(19):5847-52. Epub 2010 Jul 30.Discovery of 8-azabicyclo[3.2.1]octan-3-yloxy-benzamides as selective antagonists of the kappa opioid receptor. Part 1.
Ref 531117Bioorg Med Chem Lett. 2010 Oct 1;20(19):5847-52. Epub 2010 Jul 30.Discovery of 8-azabicyclo[3.2.1]octan-3-yloxy-benzamides as selective antagonists of the kappa opioid receptor. Part 1.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.